On 2025-05-13, Quince Therapeutics, Inc. (QNCX) announced earnings per share of $-0.34 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.24.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.28 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.24 | $-0.34 |
| 2025-03-24 | 2024-12-31 | $-0.19 | $-0.28 |
| 2024-11-13 | 2024-09-30 | -- | $-0.13 |
| 2024-08-13 | 2024-06-30 | -- | $-0.18 |
| 2024-05-13 | 2024-03-31 | -- | $-0.26 |
| 2024-04-01 | 2023-12-31 | -- | $-0.21 |
| 2023-11-14 | 2023-09-30 | -- | $-0.15 |
| 2023-08-03 | 2023-06-30 | -- | $-0.14 |
| 2023-05-15 | 2023-03-31 | -- | $-0.34 |
| 2023-03-15 | 2022-12-31 | -- | $-0.13 |
| 2022-11-09 | 2022-09-30 | -- | $-0.22 |
| 2022-08-09 | 2022-06-30 | $-0.74 | $-0.51 |
| 2022-05-10 | 2022-03-31 | $-0.64 | $-0.72 |
| 2022-03-01 | 2021-12-31 | -- | $-0.78 |
| 2021-10-29 | 2021-09-30 | $-0.73 | $-0.73 |
| 2021-08-09 | 2021-06-30 | $-0.70 | $-0.74 |
| 2021-05-10 | 2021-03-31 | $-0.63 | $-0.78 |
| 2021-03-01 | 2020-12-31 | -- | $-0.69 |
| 2020-11-12 | 2020-09-30 | $-0.60 | $-0.73 |
| 2020-08-17 | 2020-06-30 | $-0.63 | $-0.60 |
| 2020-05-12 | 2020-03-31 | $-0.43 | $-0.61 |
| 2020-03-17 | 2019-12-31 | $-0.39 | $-0.46 |
| 2019-11-12 | 2019-09-30 | -- | $-0.37 |
| 2019-08-09 | 2019-06-30 | -- | $-0.57 |
| 2019-06-12 | 2019-03-31 | -- | $-1.61 |